510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K150602Substantially Equivalent

CR3 Keyless Split Sample Cup Morphine - Methamphetamine

Guangzhou Wondfo Biotech Co., Ltd., Guangzhou, CN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K150602 is the FDA 510(k) clearance record for CR3 Keyless Split Sample Cup Morphine - Methamphetamine, a class II device, cleared for Guangzhou Wondfo Biotech Co., Ltd. on under FDA product code DNK (Thin Layer Chromatography, Morphine). FDA records list 43 510(k) clearances for Guangzhou Wondfo Biotech Co., Ltd., from to . As of , FDA records show no recalls naming K150602.

Clearance record

Decision date
Received
(28 days to decision)
Product code
DNK Thin Layer Chromatography, Morphine
Regulation
21 CFR 862.3640
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Guangzhou Wondfo Biotech Co., Ltd. Wondfo Scientech Park, Guangzhou, CN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code DNK

Trailing 12 months

FDA records hold no clearances under product code DNK in the trailing twelve months.

FDA records show no clearances under product code DNK in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DNK, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260